FB102

· Forte Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FB102, covering 2025-11-20 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo [Phase 1]